Teriflunomide Tablet, Film Coated
Product Images NDC 69539-316

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Teriflunomide (NDC 69539-316). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Msn Laboratories Private Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Blister-foil-14-mg (Teriflunomide Blister Foil 14mg)

Packaging label for Teriflunomide Tablets 14 mg film-coated oral tablets by MSN Laboratories Private Limited. The label includes a 28-tablet calendar pack with pentagon-shaped spaces for each tablet labeled by day (Day 1 to Day 14, repeated twice). The front panel displays the product name, strength in a red box, prescribing information (Rx only), and dispensing instructions. Manufacturing and distribution details are also listed.*

FDA Label Image

Foil-7-mg (Teriflunomide Blister Foil 7mg)

Teriflunomide Tablets 7 mg oral film-coated tablets packaging label from MSN Laboratories Private Limited. The label includes a 28-tablet blister card marked with days for a 14-day supply and displays the NDC 69539-032-41. The packaging also provides manufacturer and distributor information and includes a note to dispense the enclosed Medication Guide to each patient.*

FDA Label Image

Carton-14-mg (Teriflunomide Carton 14mg)

Teriflunomide Tablets 14 mg film-coated oral tablets packaging label. Contains 28 tablets. Label shows manufacturer MSN Laboratories Private Limited, located in Telangana, India, and distributor MSN Pharmaceuticals Inc., Piscataway, NJ, USA. Includes dosage instructions, storage conditions, an NDC code 69539-033-41, and a barcode. The label features the MSN logo and dispensing information.*

FDA Label Image

Carton-7-mg (Teriflunomide Carton 7mg)

Teriflunomide Tablets 7 mg film-coated tablets packaging label. The box contains 28 tablets and is labeled for oral use, prescription only. The label includes dosage instructions, storage conditions, and a warning to keep out of reach of children. Manufactured by MSN Laboratories Private Limited, India, and distributed by MSN Pharmaceuticals Inc., Piscataway, NJ. The label features the NDC 69539-032-41 and MSN logo.*

FDA Label Image

Fig-01 (Teriflunomide Figure 1)

A line graph illustrating disability progression sustained for 12 weeks as a percentage over time up to 108 weeks, comparing placebo, 7 mg Teriflunomide, and 14 mg Teriflunomide groups. The graph includes a table of the number of subjects at risk during various weeks for each group and highlights statistical significance for 14 mg versus placebo (p<0.05).*

FDA Label Image

Figure (Teriflunomide Figure 2)

A line graph showing Disability Progression Sustained for 12 weeks (%) over time in weeks for Teriflunomide 7 mg, Teriflunomide 14 mg, and placebo. The x-axis represents weeks (0 to 108) and the y-axis shows disability progression percentage (0 to 40%). Three curves depict cumulative disability progression percentages, with placebo highest at around 21.1%, 7 mg Teriflunomide about 19.7%, and 14 mg Teriflunomide lowest at 15.8%, marked with statistical significance versus placebo (p<0.05). The graph includes a number-at-risk table for each group across time points.*

FDA Label Image

Pouch-14-mg (Teriflunomide Pouch 14mg)

Packaging label for Teriflunomide Tablets 14 mg, film-coated oral tablets distributed by MSN Pharmaceuticals Inc. The label indicates the product is prescription-only, contains 28 tablets, and includes a medication guide. The labeler is MSN Laboratories Private Limited, India.*

FDA Label Image

Pouch-7-mg (Teriflunomide Pouch 7mg)

Packaging label for Teriflunomide tablets, 7 mg strength, film-coated oral tablets. The label indicates a package size of 28 tablets, prescription only, distributed by MSN Pharmaceuticals Inc. and manufactured by MSN Laboratories Private Limited in India. The label includes the NDC 69539-032-41 and the MSN logo.*

FDA Label Image

Structure (Teriflunomide Structure)

Chemical structure diagram of the active ingredient Teriflunomide, showing its molecular configuration including aromatic rings and functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.